DK0548680T3 - Beta-oxo-beta-benzenpropanthioamidderivater - Google Patents
Beta-oxo-beta-benzenpropanthioamidderivaterInfo
- Publication number
- DK0548680T3 DK0548680T3 DK92121020T DK92121020T DK0548680T3 DK 0548680 T3 DK0548680 T3 DK 0548680T3 DK 92121020 T DK92121020 T DK 92121020T DK 92121020 T DK92121020 T DK 92121020T DK 0548680 T3 DK0548680 T3 DK 0548680T3
- Authority
- DK
- Denmark
- Prior art keywords
- group
- beta
- hydrogen atom
- alkyl
- atom
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 230000010339 dilation Effects 0.000 abstract 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 abstract 1
- 208000004232 Enteritis Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 102000004257 Potassium Channel Human genes 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 108020001213 potassium channel Proteins 0.000 abstract 1
- 210000002460 smooth muscle Anatomy 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/02—Monothiocarboxylic acids
- C07C327/04—Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C327/12—Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/46—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C327/44—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34565791 | 1991-12-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0548680T3 true DK0548680T3 (da) | 1998-09-23 |
Family
ID=18378084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92121020T DK0548680T3 (da) | 1991-12-26 | 1992-12-09 | Beta-oxo-beta-benzenpropanthioamidderivater |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5332833A (cs) |
| EP (1) | EP0548680B1 (cs) |
| JP (1) | JP2707936B2 (cs) |
| KR (1) | KR930012698A (cs) |
| AT (1) | ATE163410T1 (cs) |
| CA (1) | CA2086210A1 (cs) |
| DE (1) | DE69224507T2 (cs) |
| DK (1) | DK0548680T3 (cs) |
| ES (1) | ES2113399T3 (cs) |
| GR (1) | GR3026240T3 (cs) |
| TW (1) | TW242138B (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE163410T1 (de) * | 1991-12-26 | 1998-03-15 | Mitsubishi Chem Corp | Beta-oxo-beta-benzenepropanthioamidderivate |
| WO1996022086A1 (fr) * | 1995-01-17 | 1996-07-25 | Mitsubishi Chemical Corporation | MEDICAMENT CONTENANT UN DERIVE DE β-OXO-β-BENZENEPROPANE-THIOAMIDE |
| EP1057485B1 (en) * | 1998-01-14 | 2005-05-11 | Nippon Shinyaku Co., Ltd. | Potassium channel activators |
| KR100863659B1 (ko) * | 2001-04-16 | 2008-10-15 | 미쓰비시 타나베 파마 코퍼레이션 | 질소-함유 헤테로시클릭 화합물 및 이를 포함하는 제약 조성물 |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| EP1465869B1 (en) | 2001-12-21 | 2013-05-15 | Exelixis Patent Company LLC | Modulators of lxr |
| ES2600460T3 (es) | 2005-05-10 | 2017-02-09 | Intermune, Inc. | Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés |
| MX2010012848A (es) | 2008-06-03 | 2011-03-01 | Intermune Inc | Compuestos y metodos para tratar trastornos inflamatorios y fibroticos. |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| MX382781B (es) | 2014-04-02 | 2025-03-13 | Intermune Inc | Piridinonas anti-fibroticas. |
| US10112929B2 (en) | 2015-03-09 | 2018-10-30 | Bristol-Myers Squibb Company | Lactams as inhibitors of rock |
| KR102512548B1 (ko) | 2017-12-22 | 2023-03-22 | 삼성디스플레이 주식회사 | 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2460909C2 (de) * | 1974-12-21 | 1986-02-27 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von alpha- Oxothiodimethylamiden |
| JPS5444660A (en) * | 1977-08-29 | 1979-04-09 | Yamanouchi Pharmaceut Co Ltd | Heterocyclic compound and its preparation |
| US4299845A (en) * | 1980-04-14 | 1981-11-10 | Schering Corporation | Dermatological compositions and methods of use therefor |
| GB8530015D0 (en) * | 1985-12-05 | 1986-01-15 | Ici Plc | Biologically active amide derivatives |
| US4851526A (en) * | 1987-09-04 | 1989-07-25 | Schering A.G. | 1-(4-Substituted phenyl)-1H-imidazoles compounds |
| US5185375A (en) * | 1987-12-18 | 1993-02-09 | May & Baker Limited | Thioformamide derivatives |
| ATE163410T1 (de) * | 1991-12-26 | 1998-03-15 | Mitsubishi Chem Corp | Beta-oxo-beta-benzenepropanthioamidderivate |
-
1992
- 1992-12-09 AT AT92121020T patent/ATE163410T1/de not_active IP Right Cessation
- 1992-12-09 DK DK92121020T patent/DK0548680T3/da active
- 1992-12-09 DE DE69224507T patent/DE69224507T2/de not_active Expired - Fee Related
- 1992-12-09 EP EP92121020A patent/EP0548680B1/en not_active Expired - Lifetime
- 1992-12-09 ES ES92121020T patent/ES2113399T3/es not_active Expired - Lifetime
- 1992-12-16 TW TW081110096A patent/TW242138B/zh active
- 1992-12-22 JP JP4342691A patent/JP2707936B2/ja not_active Expired - Lifetime
- 1992-12-22 KR KR1019920025062A patent/KR930012698A/ko not_active Abandoned
- 1992-12-23 CA CA002086210A patent/CA2086210A1/en not_active Abandoned
- 1992-12-23 US US07/996,404 patent/US5332833A/en not_active Expired - Fee Related
-
1994
- 1994-04-22 US US08/231,123 patent/US5439927A/en not_active Expired - Fee Related
-
1998
- 1998-02-26 GR GR980400255T patent/GR3026240T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69224507D1 (de) | 1998-04-02 |
| KR930012698A (ko) | 1993-07-21 |
| JP2707936B2 (ja) | 1998-02-04 |
| TW242138B (cs) | 1995-03-01 |
| US5439927A (en) | 1995-08-08 |
| JPH05246980A (ja) | 1993-09-24 |
| GR3026240T3 (en) | 1998-05-29 |
| CA2086210A1 (en) | 1993-06-27 |
| ATE163410T1 (de) | 1998-03-15 |
| EP0548680B1 (en) | 1998-02-25 |
| EP0548680A1 (en) | 1993-06-30 |
| DE69224507T2 (de) | 1998-08-20 |
| ES2113399T3 (es) | 1998-05-01 |
| US5332833A (en) | 1994-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR940019701A (ko) | N-헤테로아릴-n'-페닐우레아 유도체, 그의 제조방법 및 용도 | |
| DE3677452D1 (de) | Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| NO174711C (no) | Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive pyrimidindionderivater | |
| FI892787A0 (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi | |
| CA2119572A1 (en) | Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs | |
| ATE163410T1 (de) | Beta-oxo-beta-benzenepropanthioamidderivate | |
| DE69120100D1 (de) | Annelierte Thiophen-Derivate, ihre Herstellung und Verwendung | |
| DE69120581D1 (de) | 1,8-Naphthyridin-2-on-Derivate | |
| TR199902495T2 (xx) | Bile�imler. | |
| NO975666L (no) | Pyrrolderivater og medisinsk sammensetning | |
| DE3773415D1 (de) | Flavonkarbonsaeure-derivate. | |
| DE69215694D1 (de) | Benzamid-derivate | |
| ATE18196T1 (de) | 1,4-acyloxynaphthalenderivate, diese enthaltende kompositionen, verfahren fuer ihre herstellung und zwischenprodukte dafuer. | |
| EP1550651A4 (en) | GLYZERINDERIVAT | |
| NO177995C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater | |
| EP1219605A4 (en) | Urea compounds, process for producing the same and use thereof | |
| RO115873B1 (ro) | Derivaţi de acid hidroximic, procedee de obţinere a acestora, intermediari pentru realizarea unuia dintre procedee şi compoziţie farmaceutică | |
| EP0322153A3 (en) | Heterocyclic oxophtalazinyl acetic acids | |
| DE69428206D1 (de) | Chinolincarbonsäurederivate und ihre salze | |
| DE69130266D1 (de) | Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel | |
| EA199900460A1 (ru) | Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные | |
| ES2193168T3 (es) | Nuevos derivados de acido parabanico como inhibidores de aldosa reductasa. | |
| NO960308L (no) | Terapeutisk aktive benzoksaziner og benzotioanoner | |
| WO2003018564A1 (fr) | Inhibiteur d'acat selectif de la paroi vasculaire | |
| FR2823749B1 (fr) | Phenyl- et pyridyl-piperidines, procede pour leur preparation et compositions pharmaceutiques les contenant |